Results 151 to 160 of about 2,012 (174)

Heparan Sulfate Provides a Mechanism to Respond to FGFR2b and Control Regenerative Expansion [PDF]

open access: yesJournal of Cell Communication and Signaling, 2015
Fast varying 3-O-sulfated groups in epithelial KIT+ progenitors provides a cellular mechanism to respond to FGFR2b-mediated signaling and expansion of fetal and adult progenitors. This is allowed by the synthesis of 3-O-sulfated heparan sulfate that up-regulate KIT and 3-O-sulfotransferase enzymes, augmenting 3-O-sulfated heparan sulfate.
Enrique Brandan
exaly   +6 more sources

FGFR2b Protein Overexpression: An Emerging Biomarker in Gastric and Gastroesophageal Junction Adenocarcinoma

open access: yesCancer Treatment Reviews
Gastric and gastroesophageal junction cancer (G/GEJC) is a heterogeneous and complex disease characterized by histologic and molecular subtypes. Although a growing number of treatments have improved survival outcomes in the advanced setting, the greatest therapeutic benefits are observed among patient populations eligible for biomarker-directed ...
Atsushi Ochiai   +2 more
exaly   +3 more sources
Some of the next articles are maybe not open access.

Related searches:

Abstract 3778: Preclinical evaluation of BG-C137, a potential first-in-class FGFR2b-targeting ADC, for the treatment of FGFR2b-expressing cancer

Cancer Research
Fibroblast growth factor receptor 2b (FGFR2b, FGFR2IIIb), an alternative splicing isoform of FGFR2, is a receptor tyrosine kinases that activates multiple signaling cascades upon binding of FGFs, promoting cancer cell proliferation. It is also a tumor associated antigen overexpressed in multiple solid tumor types, especially gastric cancer (GC). Indeed,
Yibin Xu   +18 more
openaire   +1 more source

Abstract LB227: ALK201, a first-in-class FGFR2b-targeting antibody-drug conjugate for patients with FGFR2b+ gastric cancer and other solid tumors

Cancer Research
Abstract Background: Fibroblast growth factor receptor-2b (FGFR2b) is a receptor tyrosine kinase mainly expressed on epithelial cells and involved in numerous cellular functions. Overexpression of FGFR2b in solid tumors, especially gastric cancer, is associated with poor prognosis, making it a ...
Jiajia Pan   +6 more
openaire   +1 more source

Role of FGFR2b signaling pathway in the development of ectodermal derivatives

2015
The Fibroblast growth factor (FGF) family consists of 23 members, which play important roles during development, homeostasis and pathogenesis by controlling proliferation, migration and differentiation of cells in multiple organs. Among FGFs, we are interested in the role of FGF10 and its receptor, FGFR2b in development of ectodermal derivatives such ...
openaire   +1 more source

Effects of FGFR2b-ligand signaling on pancreatic branching morphogenesis and postnatal islet function

Journal of Molecular Histology
Pancreatic development is a complex process vital for maintaining metabolic balance, requiring intricate interactions among different cell types and signaling pathways. Fibroblast growth factor receptors 2b (FGFR2b)-ligands signaling from adjacent mesenchymal cells is crucial in initiating pancreatic development and differentiating exocrine and ...
Li-Li, Jin   +10 more
openaire   +2 more sources

Generation of Rat Lungs by Blastocyst Complementation in Fgfr2b-Deficient Mouse

SSRN Electronic Journal, 2022
Shunsuke Yuri   +2 more
openaire   +1 more source

Abstract 2964: SCR-A002, a novel FGFR2b-targeting ADC for solid tumors

Cancer Research
Abstract Background: FGFR2b (fibroblast growth factor receptor 2 IIIb), an isoform of transmembrane tyrosine kinase FGFR family, is overexpressed in various cancers, including gastric, esophageal, breast, hepatocellular, pancreatic, ovary, uterine, cervical, endometrial, lung, colorectal cancers ...
Yayuan Fu   +5 more
openaire   +1 more source

Expression of FGFR2b and HER2 in gastric cancer: Implications for targeted therapy selection.

Journal of Clinical Oncology
e16106 Background: FGFR2b and HER2 are clinically relevant therapeutic targets in gastric cancer (GC), with multiple targeted agents demonstrating efficacy in biomarker-selected patient populations.
Fei Chu   +8 more
openaire   +1 more source

FGF10 Mitigates Doxorubicin-Induced Myocardial Toxicity in Mice via Activation of FGFR2b/PHLDA1/AKT Axis

Acta Pharmacologica Sinica, 2023
Xiao-Kun Li, Wei-Wei Yang, Hui-Jing Xu
exaly  

Home - About - Disclaimer - Privacy